Robert J. Gould
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert J. Gould
Robert J. Gould is recorded as CEO at Fulcrum Therapeutics, Inc. (FULC). Fulcrum Therapeutics, Inc. reported in an 8-K filed January 4, 2023 that Robert J. Gould was appointed interim president and chief executive officer, effective January 3, 2023. The proxy statement of Fulcrum Therapeutics, Inc. reports total compensation of $424,501 for Robert J. Gould in fiscal 2023, including a base salary of $300,000. Disclosed compensation is on record for 5 fiscal years.
“On January 3, 2023, the board of directors of Fulcrum, or the Board, appointed Robert J. Gould, former chief executive officer and president and current Class III director, as interim president and chief executive officer and as Fulcrum's principal executive officer, effective January 3, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-03–present
-
Start not stated–2021-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fulcrum Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alex C. Sapir CEO, Board Member
- Bryan Stuart CEO, COO, Board Member
- Kate Haviland Chairman
- Mark Levin Chairman
- Alan A. Musso CFO
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
- Gregory Tourangeau Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Fulcrum Therapeutics, Inc. (FULC) | Former Interim President and Chief Executive Officer | $300,000 | $424,501 |
| 2022 | Fulcrum Therapeutics, Inc. (FULC) | Former Interim President and Chief Executive Officer | — | $118,342 |
| 2020 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer | $535,000 | $3,016,350 |
| 2019 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer | $478,195 | $3,889,353 |
| 2018 | Fulcrum Therapeutics, Inc. (FULC) | President and Chief Executive Officer Bryan Stuart .^ | $442,900 | $853,634 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.